PubMed Health⌕ Search

Biomedical subjects

R B Lewis

Publications and source records attributed to R B Lewis.

At least 19 recordsLinked to original sources

Bandage soft contact lens barrier function: a clinical research note.

Corneal thickness pre- and post-operatively was measured on 18 volunteer subjects within the context of a clinical investigation of laser refractive surgery. All measurements were taken with regard for time of day, in order to counter any complicating diurnal influence on data accuracy. Of the 18 subjects, six lost or had accidently displaced their overnight bandage soft contact lenses the first night immediately after surgery, and 12 retained theirs. The individuals with lost bandage lenses exhibited uniformly thick, swollen corneas. In contrast, the other 12 subjects, with retained lenses, exhibited a stable corneal thickness map, displaying the characteristic relatively thick periphery that transitions to a thinner central region. Moreover, in the six affected subjects, application of a new overnight bandage lens resulted in recovery of the normal thickness pattern on day 2, as opposed to the uniform swelling or oedema of the previous day. In combination, these findings indicate a fluid barrier function on behalf of the bandage soft contact lenses, which allowed the corneal endothelial pump mechanism to counteract any extreme swelling or fluid accumulation. This previously unreported phenomenon helps explain the historical effectiveness of this treatment regimen for corneal bullous, or excessive fluid-retention, conditions.

Journal Article↗

Neonatal cleft lip repair in Ayrshire; a contribution to the debate.

Neonatal cleft lip repair has been the normal practice in Ayrshire, Scotland, for the last 10 years. The surgical results are briefly presented. Anaesthetic and paediatric considerations are discussed. Assuming careful preoperative assessment is made, the procedure carries minimal morbidity, can give good results and is believed to offer distinct advantages to the parents and child.

Cleft Lip↗

Assessment of a scavenging device for use in paediatric anaesthesia.

We describe a scavenging device, primarily for use during inhalation induction of anaesthesia in children; it was designed to optimize the often conflicting requirements of clinical acceptability and adequate gas collection. The performance was assessed in three ways. The device reduced the nitrous oxide concentration in the breathing zone of the anaesthetist during inhalation induction to about 100 p.p.m. We also describe a method to measure the direct catchment of nitrous oxide expressed as a percentage of the total nitrous oxide used. In 46 patients the mean percentage collection was 82%. Using personal sampling devices, we found that comprehensive scavenging in paediatric anaesthesia can reduce the average exposure of anaesthetists to about 130 p.p.m. of nitrous oxide.

Air Pollutants, Occupational↗

The Ruben circle anaesthesia system. An investigation of reverse flow of patient expired gas during spontaneous breathing.

The Ruben circle anaesthesia system was studied in the spontaneous breathing mode, and under certain conditions there was incompetence of the replaceable mushroom control valve. This causes a reverse flow of gas which results in rebreathing of expired gas when the system is used on spontaneously breathing patients. A patient simulator was used to investigate the way in which the reverse flow of gas depends on ventilatory parameters and fresh gas flow. The inspired concentration of carbon dioxide increased for increased fresh gas flow and for decreased tidal volume. These results were confirmed by observations on anaesthetised adult and paediatric patients during spontaneous breathing. We conclude that the system in its present form, is not suitable for use on spontaneously breathing paediatric patients.

Adult↗

Halothane hepatitis in a young child.

A 4-year-old girl developed severe hepatitis following the fourth administration of halothane in a period of 5 months. She was shown to have a circulating antibody which acted specifically against rabbit hepatocyte previously sensitized to halothane. The patient made a full recovery from the hepatitis, but 5 months later, developed diabetes mellitus.

Anesthesia, Inhalation↗

Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation.

Non-virus-producing hematopoietic cells transformed in vitro by reticuloendotheliosis virus (REV-T) induce lethal "reticuloendotheliosis" when inoculated into histocompatible chickens. This is the first direct demonstration that an in vivo target cell of an avian acute leukemia virus can be transformed in vitro. The tumorigenic, REV-T-transformed non-virus-producing cells fail to express helper-virus-coded proteins. REV-T transformed tumorigenic cells therefore do not require helper-virus functions. Cells transformed in vivo or in vitro by REV-T have lymphoblastoid morphology and express low levels of terminal-deoxynucleotidyl-transferase activity and bursal-cell determinants. One clone synthesized Ig mu. The preferred target cells for REV-T transformation are therefore immature lymphoid cells that express B-cell determinants. We propose that the unique transforming sequence of REV-T be designated rel (lymphoid).

Animals↗

Assembly of avian reticuloendotheliosis virus: association of the core precursor polypeptide with the intracellular ribonucleoprotein complex.

A virus-specific ribonucleoprotein complex is present in the cytoplasm of reticuloendotheliosis virus-transformed chicken bone marrow cells. This ribonucleoprotein complex contains viral reverse transcriptase activity and may represent a precursor to the budding virion. The major viral polypeptide associated with the ribonucleoprotein complex was a polypeptide with a molecular weight of 63,000. This protein exhibited a precursor-product relationship with the major reticuloendotheliosis virus structural core protein p29. Core polypeptides were not associated with the intracellular ribonucleoprotein complex. Thus, p29 was incorporated into the virion in the form of its precursor Pr63. The cleavage of Pr63 in the ribonucleoprotein complex was accomplished either during the budding process of shortly after the release of particles from the cell.

Animals↗